Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James L Riley

Showing results (41-50 of 127) with videos related to

Pageof 13
Sort By:
Molecular Therapy. Methods & Clinical Development|April 25, 2018
Improved Expansion and <i>In Vivo</i> Function of Patient T Cells by a Serum-free MediumAndrew R Medvec, Christopher Ecker, Hong Kong, et al.
Journal of Virology|September 5, 2008
Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alphaMax W Richardson, Richard G Carroll, Matthew Stremlau, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 2, 2013
Cutting Edge: a novel, human-specific interacting protein couples FOXP3 to a chromatin-remodeling complex that contains KAP1/TRIM28Chunjian Huang, Sunil Martin, Christian Pfleger, et al.
Cancer Immunology, Immunotherapy : CII|November 6, 2010
Topoisomerase inhibitors modulate expression of melanocytic antigens and enhance T cell recognition of tumor cellsTimothy J Haggerty, Ian S Dunn, Lenora B Rose, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 24, 2013
Strength of PD-1 signaling differentially affects T-cell effector functionsFang Wei, Shi Zhong, Zhengyu Ma, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2002
Human CD8+ T cells do not require the polarization of lipid rafts for activation and proliferationBirgit Kovacs, Marcela V Maus, James L Riley, et al.
Journal of Immunological Methods|August 4, 2020
Characterization of CAR T cell expansion and cytotoxic potential during Ex Vivo manufacturing using image-based cytometryColby R Maldini, Andrea C Love, Kevin W Tosh, et al.
Journal of Translational Medicine|August 11, 2011
Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytesQunrui Ye, Maria Loisiou, Bruce L Levine, et al.
Cancer Research|January 21, 2006
Prostaglandin E2 impairs CD4+ T cell activation by inhibition of lck: implications in Hodgkin's lymphomaJens M Chemnitz, Julia Driesen, Sabine Classen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 21, 2022
HIV-1-Infected CD4<sup>+</sup> T Cells Present MHC Class II-Restricted Epitope via Endogenous ProcessingMary M Addison, Gavin I Ellis, George J Leslie, et al.
Pageof 13

Showing results (41-50 of 127) with videos related to

Sort By:
Pageof 13
Molecular Therapy. Methods & Clinical Development|April 25, 2018
Improved Expansion and <i>In Vivo</i> Function of Patient T Cells by a Serum-free MediumAndrew R Medvec, Christopher Ecker, Hong Kong, et al.
Journal of Virology|September 5, 2008
Mode of transmission affects the sensitivity of human immunodeficiency virus type 1 to restriction by rhesus TRIM5alphaMax W Richardson, Richard G Carroll, Matthew Stremlau, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 2, 2013
Cutting Edge: a novel, human-specific interacting protein couples FOXP3 to a chromatin-remodeling complex that contains KAP1/TRIM28Chunjian Huang, Sunil Martin, Christian Pfleger, et al.
Cancer Immunology, Immunotherapy : CII|November 6, 2010
Topoisomerase inhibitors modulate expression of melanocytic antigens and enhance T cell recognition of tumor cellsTimothy J Haggerty, Ian S Dunn, Lenora B Rose, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 24, 2013
Strength of PD-1 signaling differentially affects T-cell effector functionsFang Wei, Shi Zhong, Zhengyu Ma, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 7, 2002
Human CD8+ T cells do not require the polarization of lipid rafts for activation and proliferationBirgit Kovacs, Marcela V Maus, James L Riley, et al.
Journal of Immunological Methods|August 4, 2020
Characterization of CAR T cell expansion and cytotoxic potential during Ex Vivo manufacturing using image-based cytometryColby R Maldini, Andrea C Love, Kevin W Tosh, et al.
Journal of Translational Medicine|August 11, 2011
Engineered artificial antigen presenting cells facilitate direct and efficient expansion of tumor infiltrating lymphocytesQunrui Ye, Maria Loisiou, Bruce L Levine, et al.
Cancer Research|January 21, 2006
Prostaglandin E2 impairs CD4+ T cell activation by inhibition of lck: implications in Hodgkin's lymphomaJens M Chemnitz, Julia Driesen, Sabine Classen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 21, 2022
HIV-1-Infected CD4<sup>+</sup> T Cells Present MHC Class II-Restricted Epitope via Endogenous ProcessingMary M Addison, Gavin I Ellis, George J Leslie, et al.
Pageof 13